You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ibrutinib

Showing 351 - 368 of 368
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia With 17p Deletion, Small Lymphocytic Lymphoma With 17p Deletion Trial in Worldwide (Ibrutinib)

Completed
Has Results
  • Chronic Lymphocytic Leukemia With 17p Deletion
  • Small Lymphocytic Lymphoma With 17p Deletion
  • Ibrutinib
  • Phoenix, Arizona
  • +54 more
Jan 9, 2017

Diffuse Large Cell B-lymphoma Trial in United States (ibrutinib)

Completed
Has Results
  • Diffuse Large Cell B-lymphoma
  • ibrutinib
  • Los Angeles, California
  • +14 more
Mar 2, 2017

Healthy Trial in Merksem (Ibrutinib, Moxifloxacin, Ibrutinib-matching )

Completed
  • Healthy
  • Ibrutinib
  • +3 more
  • Merksem, Belgium
    (unnamed)
Jun 3, 2016

Leukemia, Lymphocytic, Chronic, B-Cell Trial (Ibrutinib combined with As2O3, ibrutinib)

Unknown status
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Ibrutinib combined with As2O3
  • ibrutinib
  • (no location specified)
Apr 27, 2016

Core: Relapsed or Refractory DLBCL, Module 1: Non-GCB DLBCL Trial (AZD2014, Ibrutinib)

Withdrawn
  • Core: Relapsed or Refractory Diffuse Large B-Cell Lymphoma
  • Module 1: Non-GCB Diffuse Large B-Cell Lymphoma
  • (no location specified)
Sep 14, 2016

Mantle Cell Lymphoma Trial (acalabrutinib, ibrutinib, rituximab)

Withdrawn
  • Mantle Cell Lymphoma
  • (no location specified)
May 12, 2016

Healthy Trial in Antwerpen (Ibrutinib, Omeprazole)

Completed
  • Healthy
  • Antwerpen, Belgium
    (unnamed)
Apr 14, 2016

Recurrent Mature B-cell Tumors Trial in Japan (PCI-32765)

Completed
  • Recurrent Mature B-cell Neoplasms
  • Kyoto, Japan
  • +3 more
Feb 1, 2018

Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

Completed
  • Mantle Cell Lymphoma
  • Ibrutinib
  • La Jolla, California
  • +56 more
May 27, 2016

Healthy Trial in Antwerpen (Ibrutinib (Treatment A) [Reference], Ibrutinib (Treatment B), Ibrutinib (Treatment C))

Completed
  • Healthy
  • Ibrutinib (Treatment A) [Reference]
  • +5 more
  • Antwerpen, Belgium
    (unnamed)
Dec 21, 2015

Adult B Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia, Cutaneous B-Cell Non-Hodgkin Lymphoma Trial in United States

Terminated
  • Adult B Acute Lymphoblastic Leukemia
  • +28 more
  • Ibrutinib
  • +2 more
  • Los Angeles, California
  • +6 more
Aug 18, 2015

B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocyctic Leukemia Trial in Columbus (PCI-32765,

Completed
Has Results
  • B-cell Chronic Lymphocytic Leukemia
  • +3 more
  • Columbus, Ohio
    The Ohio State University
May 28, 2015

Healthy Participants Trial in Merksem (Ibrutinib)

Completed
  • Healthy Participants
  • Ibrutinib
  • Merksem, Belgium
    (unnamed)
Nov 4, 2014

Determining Resistance to Ibrutinib

Unknown status
  • Mantle Cell Lymphoma
  • Chronic Lymphocytic Leukaemia
    • Sutton, Surrey, United Kingdom
      The Royal Marsden NHS Foundation Trust
    Oct 14, 2014

    Mantle Cell Lymphoma Trial in Worldwide (PCI-32765)

    Completed
    Has Results
    • Mantle Cell Lymphoma
    • Stanford, California
    • +17 more
    Aug 24, 2015

    Healthy Volunteer Trial in Neptune (Treatment A: PCI-32765, Treatment B: PCI-32765)

    Completed
    • Healthy Volunteer
    • Treatment A: PCI-32765
    • Treatment B: PCI-32765
    • Neptune, New Jersey
      (unnamed)
    Feb 12, 2014

    Healthy Trial in Neptune (Ibrutinib, Ketoconazole)

    Completed
    • Healthy
    • Neptune, New Jersey
      (unnamed)
    Jun 18, 2013

    B-cell Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in United States (PCI-32765)

    Completed
    Has Results
    • B-cell Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Boston, Massachusetts
    • +5 more
    Jul 17, 2014